Axys Pharmaceuticals

About:

AXYS Pharmaceuticals is engaged in the discovery and development of therapeutic small molecules.

Website: http://www.axyspharm.com

Top Investors: SV Health Investors

Description:

AXYS Pharmaceuticals, Inc. is engaged in discovery, design, and development of therapeutic small molecules that addressed significant markets with major unmet medical needs. It collaborates with large pharmaceutical companies in discovering therapeutics for chronic diseases. In addition, it also discovers and develops therapeutics for the treatment of various types of cancer and other specialty therapeutic opportunities. AXYS Pharmaceuticals, Inc. was formerly known as Arris Pharmaceuticals, Incorporated. The company is based in South San Francisco, California. As of November 16, 2001, AXYS Pharmaceuticals, Inc. operates as a subsidiary of Celera Corporation.

Total Funding Amount:

$31.5M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

1989-01-01

Founders:

Number of Employees:

251-500

Last Funding Date:

2014-11-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai